Literature DB >> 24819646

From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases?

C Tomasini1, F Derlino, P Quaglino, M Caproni, G Borroni.   

Abstract

Erythema multiforme (EM), Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute bullous disorders associated to different prognosis, mainly due to infections and drugs. More in particular EM in more than 90% is caused by infections (especially Herpes virus infection), while, on the other hand SJS and TEN are referable in more than 95% of cases to drugs. Distinction among these three forms is often controversal and still debated. An attempt to distinguish these forms has been possible mainly according to anamnesis, clinical presentation (morphology, involved sites, extension of lesions) and pathogenetic mechanisms, being on the contrary more difficult from an histopathological point of view. Nowadays a clear diagnosis and a distinction from other life-threatening diseases is possible with the integration of all the mentioned aspects. Moreover, this recognition should be as early as possible in order to perform a prognostic evaluation of the case and to start supportive cares and therapies as soon as possible.

Entities:  

Mesh:

Year:  2014        PMID: 24819646

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  3 in total

1.  Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap.

Authors:  Prabhat Kumar; Ajay Chauhan; Riyaz Charaniya; Anindya Ghosh; Vaibhav Tandon
Journal:  J Clin Diagn Res       Date:  2016-03-01

2.  Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial.

Authors:  Reason Wilken; Chin Shang Li; Victoria R Sharon; Kyoungmi Kim; Falin B Patel; Forum Patel; Emanual Maverakis
Journal:  Trials       Date:  2015-08-22       Impact factor: 2.279

3.  Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015.

Authors:  Waleed M Sweileh
Journal:  Orphanet J Rare Dis       Date:  2017-01-18       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.